0000929638-23-001706.txt : 20230609 0000929638-23-001706.hdr.sgml : 20230609 20230609170827 ACCESSION NUMBER: 0000929638-23-001706 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230608 FILED AS OF DATE: 20230609 DATE AS OF CHANGE: 20230609 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BARBARI SHARON CENTRAL INDEX KEY: 0001240499 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36464 FILM NUMBER: 231006246 MAIL ADDRESS: STREET 1: 280 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER NAME: FORMER CONFORMED NAME: BARBARI SHARON SURREY DATE OF NAME CHANGE: 20030610 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AGILE THERAPEUTICS INC CENTRAL INDEX KEY: 0001261249 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 COLLEGE ROAD EAST STREET 2: SUITE 310 CITY: PRINCETON STATE: NJ ZIP: 08540-6635 BUSINESS PHONE: 609-683-1880 MAIL ADDRESS: STREET 1: 500 COLLEGE ROAD EAST STREET 2: SUITE 310 CITY: PRINCETON STATE: NJ ZIP: 08540-6635 4 1 form4.xml X0407 4 2023-06-08 0001261249 AGILE THERAPEUTICS INC AGRX 0001240499 BARBARI SHARON 500 COLLEGE ROAD EAST, SUITE 310 PRINCETON NJ 08540 true false Common Stock 2023-06-08 4 A 0 935 0 A 974 D Employee Stock Option (Right to Buy) 3.58 2023-06-08 4 A 0 1065 0 A 2033-06-07 Common Stock 1065 1065 D These shares represent restricted stock units that were granted on June 8, 2023, which will vest and be settled in common stock on June 8, 2024, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service. On April 10, 2023 the Issuer completed a one-for-fifty reverse stock split of the Issuer's common stock. This amount has been adjusted to give effect to this reverse stock split. This option was granted on June 8, 2023 and vests in full on June 8, 2024, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service. /s/ Geoffrey P. Gilmore, Attorney-in-fact 2023-06-09